Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Search Results

Your search returned 1870 record(s).

Page 162 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:

  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1611 6.1 months Metastatic colorectal cancer 5 Chemotherapy
The Royal Marsden United Kingdom 10/2013
Treatment Details: Patients: This phase 2 study involved 29 metastatic or recurrent colorectal cancer patients who had received prior chemotherapy. The median patient age was 66.2 years and 72.4% were male.
1612 6.0 months GBM 5 Chemotherapy
Linköping University Sweden 9/2012
Treatment Details: Patients: This phase 3 study involved newly diagnosed glioblastoma patients, all older than 60 years, who were divided into three separate treatment groups. Group A was composed of 93 pati
1613 6.0 months Advanced NSCLC 5 Chemotherapy
Aichi Cancer Center Aichi Hospital Japan 2/2012
Treatment Details: Patients: This phase 2 study involved advanced non-small cell lung cancer patients with no previous chemotherapy who were divided into two separate treatment groups. In group A, there were
1614 6.0 months Advanced hepatocellular carcinoma 4 Biologic therapy
National Taiwan University Hospital Taiwan Region 5/2012
Treatment Details: Patients: This phase 2 study involved 19 advanced hepatocellular carcinoma patients, 18 of whom were male. The median patient age was 54 years. Treatment: Patients were treated with th
1615 6.0 months Recurrent GBM 2 Biologic therapy
Rigshospitalet Denmark 1/2013
Treatment Details: Patients: This phase 2 study involved 25 recurrent glioblastoma patients who had been previously treated. The median patient age was 55 years and 60% were male. Treatment: Patients wer
1616 6.0 months metastatic melanoma 5 Chemotherapy
University of Texas Medical Branch United States 4/2004
Treatment Details: Patients: This Phase II study involved 21 eligible patients with disseminated metastatic melanoma. The median age was 58. Treatment: The treatment consisted of a form of chemotherapy,
1617 6.0 months Recurrent GBM Chemotherapy
University of Kentucky Medical Center United States 10/2002
Treatment Details: Patients: This Phase I study involved 9 patients with recurrent glioblastoma multiforme. Treatment: Treatment consisted of escalating doses of intratumoral bleomycin (blenoxane). The
1618 6.0 months Metastatic or locally advanced NSCLC Radiation
Princess Margaret Hospital/University Health Network Canada 11/2002
Treatment Details: Patients: This Phase III trial study involved 230 patients with metastatic or locally advanced non-small cell lung cancer. Treatment: Patients were divided into two groups – one group (
1619 6.0 months Unresectable Malignant Mesothelioma 4 Chemotherapy
Alfacell Corp. United States 1/2002
Treatment Details: Patients: This Phase II study involved 105 patients with unresectable malignant mesothelioma. Treatment: The treatment consisted of administration of the drug ranpirnase (onconase).
1620 6.0 months Hepatocellular carcinoma 4 Biologic therapy
Mayo Clinic Florida United States 9/2010
Treatment Details: Patients: This phase II study involved 35 patients with surgically unresectable or metastatic hepatocellular carcinoma. The median age was 61 years and 80% of the patients were male. Tr
Page 162 of 187  | Previous Page  | Next Page